Skip to main content
. 2010 Jul 13;103(4):581–589. doi: 10.1038/sj.bjc.6605776

Table 5. UGT1A genotypes, haplotypes and toxicity.

    Haematologic
No haematologic
Neutropenia
Diarrhoea
Neutropenia and diarrhoea
Gene Genotype Yes (%) OR (95% CI) P Yes (%) OR (95% CI) P Yes (%) OR (95% CI) P Yes (%) OR (95% CI) P Yes (%) OR (95% CI) P
First cycle
 UGT1A1 *28/*28 2 (13.3) 2.14 (0.42–10.86) 0.31 6 (40) 4.92 (1.55–15.64) 0.004 1 (6.7) 1.13 (0.13–9.67) 1 4 (26.7) 3.7 (1.02–13.42) 0.036
  Other 9 (6.7) 1   16 (11.9) 1   8 (6) 1   12 (9) 1    
 UGT1A9 *1/*1 3 (5.3) 1 0.44 12 (11.9) 1 0.09 2 (3.5) 1 0.5 9 (15.8) 1 0.1
  Other 8 (8.7) 1.71 (0.44–6.75)   10 (21.1) 0.46 (0.18–1.14)   7 (7.6) 2.3 (0.45–11.3)   7 (7.6) 0.44 (0.15–1.25)    
 UGT1A7 *3/*3 2 (9.1) 1.31 (0.26–6.52) 0.74 4 (10.9) 1.35 (0.41–4.44) 0.63 8 (4.5) 0.71 (0.08–5–96) 1 2 (9.1) 0.81 (0.17–3.83) 1
  Other 9 (7.1) 1   18 (18.2) 1   1 (6.3) 1   14 (11) 1    
 All UGTs No favourable* 2 (18.2) 3.19 (0.6–17) 0.16 4 (36.4) 3.8 (1.01–14.33) 0.036 1 (9.1) 1.63 (0.18–14.32) 0.5 2 (18.2) 1.97 (0.39–10.03) 0.33
  Other 9 (6.5) 1   18 (13) 1   8 (5.8) 1   14 (10.1) 1    
 All UGTs Favourable 8 (8.9) 1 0.53 9 (10) 1 0.043 7 (7.8) 1 0.32 6 (6.7) 1 0.047
  Other 3 (5.1) 0.55 (0.14–2.16)   13 (22) 2.54 (1.01–6.41)   2 (3.4) 0.42 (0.08–2.08)   10 (16.9) 2.86 (0.98–8.34)    
                                 
Haplotypes
 I   1 1 1 1
 II   NA NA 0.33 (0.04–2.61) 0.29 0.46 (0.06–3.72) 0.47
 III   0.39 (0.08–1.81) 0.23 1.54 (0.61–3.88) 0.36 0.45 (0.10–2.06) 0.30 1.57 (0.56–4.38) 0.39
 VII   1.27 (0.48–3.38) 0.63 2.5 (1.08–5.81) 0.03 0.93 (0.32–2.72) 0.89 1.98 (0.76–5.13) 0.60
                                 
End of treatment
 UGT1A1 *28/*28 6 (40) 2.77 (0.91–8.47) 0.065 10 (66.7) 3.83 (1.23–11–86) 0.014 6 (40) 2.91 (0.95–8.92) 0.05 9 (60) 4.08 (1.36–12.28) 0.008 5 (33.3) 12.7 (3.14–51.34) <0.0001
  Other 26 (19.4) 1   46 (34.3) 1   25 (18.7) 1   36 (26.9) 1   5 (3.8) 1  
 UGT1A9 *1/*1 10 (17.5) 1 0.36 29 (50.9) 1 0.008 10 (17.5) 1 0.44 24 (42.1) 1 0.013 5 (8.9) 1 0.4
  Other 22 (23.9) 1.48 (0.64–3.4)   27 (29.3) 0.4 (0.2–0.8)   21 (22.8) 1.39 (0.6–3.2)   21 (22.8) 0.41 (0.2–0.8)   5 (5.5) 0.6 (0.16–2.15)  
 UGT1A7 *3/*3 5 (22.7) 1.09 (0.37–3.22) 0.88 12 (54.5) 2.26 (0.91–5.65) 0.075 5 (22.7) 1.14 (0.39–3.39) 0.81 11 (50) 2.74 (1.09–6.89) 0.028 4 (18.2) 4.41 (1.13–17.15) 0.022
  Other 27 (21.3) 1   44 (34.6) 1   26 (20.5) 1   34 (26.8) 1   6 (4.8) 1  
 All UGTs No favourable* 5 (45.5) 3.4 (0.97–12.1) 0.044 8 (72.7) 5 (1.27–19.72) 0.02 5 (45.5) 3.59 (1.02–12.67) 0.036 7 (63.6) 4.61 (1.28–16–63) 0.018 4 (36.4) 12.38 (2.83–54.18) <0.0001
  Favourable 27 (19.6) 1   48 (34.8) 1   26 (18.8) 1   38 (27.5) 1   6 (4.4) 1  
 All UGTs Favourable 21 (21.3) 1 0.5 26 (28.9) 1 0.007 20 (22.2) 1 0.6 20 (22.2) 1 0.009 4 (4.5) 1 0.19
  Other 11 (18.6) 0.75 (0.33–1.71)   30 (50.8) 2.55 (1.29–5.05)   11 (18.6) 0.8 (0.35–1.83)   25 (42.4) 2.57 (1.26–5.27)   6 (10.3) 2.45 (0.66–9.1)  
                                 
Haplotypes
 I   1 1 1 1 1  
 II   0.16 (0.02–1.24) 0.08 1.29 (0.53–3.16) 0.58 0.16 (0.02–1.24) 0.08 1.27 80.48–3.32) 0.63    
 III   0.58 (0.23–1.43) 0.24 1.58 (0.81–3.11) 0.18 0.55 (0.22–1.36) 0.2 1.31 (0.63–2.71) 0.47    
 VII   1.50 (0.76–2.98) 0.25 2.11 (1.12–3.98) 0.02 1.52 (0.76–3.03) 0.23 2.24 (0.63–7.24) 0.02    

Abbreviations: CI=confidence interval; NA=not applicable; OR=odds ratio;

Note: All reported P-values correspond to χ2-test or Fisher's exact test, when appropriate.

No favourable UGT1A genotypes=UGT1A1*28/*28, UGT1A7*3/*3 and UGT1A9*1/*1.